马齿苋中黄酮类及生物碱类的研究进展
Research Progress on Flavonoids and Alkaloids in Portulaca oleracea L.
DOI: 10.12677/PI.2023.124040, PDF,  被引量   
作者: 李克仙:昆明医科大学药学院曁云南省天然药物药理重点实验室,云南 昆明
关键词: 马齿苋黄酮类生物碱类药理作用药物代谢Portulaca oleracea L. Flavonoids Alkaloids Pharmacology Drug Metabolism
摘要: 马齿苋(Portulaca oleracea L.)为马齿苋属分布较广的药食同源植物。马齿苋中含有黄酮、生物碱等多种化学成分,具有抗肿瘤、神经保护、抗氧化、抑菌、保肝、抗衰老等药理作用,可用于治疗阿尔茨海默病、帕金森氏病、三阴性乳腺癌、宫颈癌、肝癌、糖尿病、高血脂等疾病。本文对近年来马齿苋中黄酮及生物碱类的化学成分、药理作用、体内代谢过程进行总结,以期为马齿苋在医药和食品方面的利用提供参考。
Abstract: Portulaca oleracea L. is a medicinal and food-homologous plant in the genus Portulaca. Purslane contains flavonoids, alkaloids and other chemical components, with anti-tumor, neuroprotective, antioxidant, bacteriostatic, hepatoprotective, anti-aging and other pharmacological effects, can be used to treat Alzheimer’s disease, Parkinson’s disease, triple-negative breast cancer, cervical cancer, liver cancer, diabetes, hyperlipidemia, and other diseases. This work summarized the chemical composition, pharmacological activities and metabolism of flavonoids and alkaloids in purslane in recent years, in order to provide reference for the utilization of purslane in medicine and food.
文章引用:李克仙. 马齿苋中黄酮类及生物碱类的研究进展[J]. 药物资讯, 2023, 12(4): 317-337. https://doi.org/10.12677/PI.2023.124040

参考文献

[1] 陈珏, 倪江, 周德尧, 等. 药食同源植物——马齿苋的研究进展[J]. 上海蔬菜, 2020(3): 86-87+96.
[2] 李明珍. 本草纲目第四册[M]. 北京: 人民卫生出版社, 1977.
[3] 苏敬. 新修本草[M]. 合肥: 安徽科学技术出版社, 1981.
[4] Jalali, J. and Ghasemzadeh Rahbardar, M. (2023) Ameliorative Effects of Portulaca oleracea L. (Purslane) and Its Active Constituents on Nervous System Disorders: A Review. Iranian Journal of Basic Medical Sciences, 26, 2-12.
[5] Liu, G., Liu, A., Yang, C., et al. (2022) Portulaca oleracea L. Organic Acid Extract Inhibits Persistent Methicillin-Resistant Staphylococcus aureus in Vitro and in Vivo. Frontiers in Microbiology, 13, Article 1076154. [Google Scholar] [CrossRef] [PubMed]
[6] Ma, Y., Bao, Y., Zhang, W., Ying, X. and Stien, D. (2020) Four Lignans from Portulaca oleracea L. and Its Antioxidant Activities. Natural Product Research, 34, 2276-2282. [Google Scholar] [CrossRef] [PubMed]
[7] Liu, F., Cui, X., Duan, Y., et al. (2022) A New Alkaloid from Portulaca oleracea L. and Its Anti-Inflammatory Activity. Natural Product Research, 36, 4709-4713. [Google Scholar] [CrossRef] [PubMed]
[8] Gu, Y., Leng, A., Zhang, W., Ying, X. and Stien, D. (2022) A Novel Alkaloid from Portulaca oleracea L. and Its Anti-Inflammatory Activity. Natural Product Research, 36, 595-600. [Google Scholar] [CrossRef] [PubMed]
[9] Zhou, Y.-X., Xin, H.-L., Rahman, K., et al. (2015) Portulaca oleracea L.: A Review of Phytochemistry and Pharmacological Effects. Biomed Research International, 2015, Article ID: 925631. [Google Scholar] [CrossRef] [PubMed]
[10] Jang, S., Lee, M.-S., Kang, S.-A., Kim, C.-T and Kim, Y. (2022) Portulaca oleracea L. Extract Regulates Hepatic Cholesterol Metabolism via the AMPK/MicroRNA-33/34α Pathway in Rats Fed a High-Cholesterol Diet. Nutrients, 14, Article No. 3330. [Google Scholar] [CrossRef] [PubMed]
[11] Ebrahimian, Z., Razavi, B.M., Mousavi Shaegh, S.A. and Hosseinzadeh, H. (2022) Effects of Portulaca oleracea L. (Purslane) on the Metabolic Syndrome: A Review. Iranian Journal of Basic Medical Sciences, 25, 1275-1285.
[12] Jalali, J. and Ghasemzadeh Rahbardar, M. (2022) Ameliorative Effects of Portu-laca oleracea L. (Purslane) on the Metabolic Syndrome: A Review. Journal of Ethnopharmacology, 299, Article ID: 115672. [Google Scholar] [CrossRef] [PubMed]
[13] De Souza, P.G., Rosenthal, A., Ayres, E.M.M. and Teodoro, A.J. (2022) Potential Functional Food Products and Molecular Mechanisms of Portulaca Oleracea L. on Anticancer Activity: A Review. Oxidative Medicine and Cellular Longevity, 2022, Article ID: 7235412. [Google Scholar] [CrossRef] [PubMed]
[14] Farkhondeh, T., Samarghandian, S., Azimi-Nezhad, M. and Hozeifi, S. (2019) The Hepato-Protective Effects of Portulaca oleracea L. Extract: Review. Current Drug Discovery Technologies, 16, 122-126. [Google Scholar] [CrossRef] [PubMed]
[15] 权美平, 郝晓宁. 马齿苋药用价值及其保健制品的研究进展[J]. 保鲜与加工, 2012, 12(5): 44-47.
[16] 张红燕, 王鹏, 李玉梅, 等. 马齿苋在化妆品中的功效研究进展[J]. 日用化学品科学, 2022, 45(12): 47-50.
[17] 刘治廷, 王忠娟, 张秀娟, 等. 马齿苋抑菌活性成分研究进展[J/OL]. 食品科学, 2022. http://kns.cnki.net/kcms/detail/11.2206.ts.20221111.1127.016.html, 2023-07-12.
[18] 唐凯俊. 马齿苋的化学成分及其活性研究[D]: [硕士学位论文]. 济南: 山东大学, 2022.
[19] Park, J.-E. and Han, J.-S. (2022) HM-Chromanone, a Major Homoisoflavonoid in Portulaca oleracea L., Improves Palmitate-Induced Insulin Resistance by Regulating Phos-phorylation of IRS-1 Residues in L6 Skeletal Muscle Cells. Nutrients, 14, Article No. 3815. [Google Scholar] [CrossRef] [PubMed]
[20] Duan, Y., Ying, Z., Zhang, M., Ying, X. and Yang, G. (2022) Two New Homoisoflavones from Portulaca oleracea L. and Their Activities. Natural Product Research, 36, 1765-1773. [Google Scholar] [CrossRef] [PubMed]
[21] 鲍守民, 贾红梅, 邹忠梅, 等. 马齿苋生物碱的研究进展[J]. 药物评价研究, 2020, 43(6): 1174-1182.
[22] Song, X., Tan, L., Wang, M., et al. (2021) Myricetin: A Review of the Most Recent Research. Biomedicine & Pharmacotherapy, 134, Article ID: 111017. [Google Scholar] [CrossRef] [PubMed]
[23] Zhao, X., Wang, J., Deng, Y., et al. (2021) Quercetin as a Pro-tective Agent for Liver Diseases: A Comprehensive Descriptive Review of the Molecular Mechanism. Phytotherapy Re-search, 35, 4727-4747. [Google Scholar] [CrossRef] [PubMed]
[24] Long, J.M. and Holtzman, D.M. (2019) Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. Cell, 179, 312-339. [Google Scholar] [CrossRef] [PubMed]
[25] 王潞, 周云英. 杨梅素抗神经系统疾病相关药理作用研究进展[J]. 海峡药学, 2019, 31(9): 14-17.
[26] 李海涛, 葛翎, 段国梅, 等. 马齿苋的化学成分及药理活性研究进展[J]. 中国野生植物资源, 2020, 39(6): 43-47.
[27] Zhao, L., Wang, J.-L., Liu, R., et al. (2013) Neuroprotective, Anti-Amyloidogenic and Neurotrophic Effects of Apigenin in an Alzheimer’s Disease Mouse Model. Molecules, 18, 9949-9965. [Google Scholar] [CrossRef] [PubMed]
[28] Zhao, L., Wang, J.-L., Wang, Y.-R. and Fa, X.-Z. (2013) Apig-enin Attenuates Copper-Mediated β-Amyloid Neurotoxicity through Antioxidation, Mitochondrion Protection and MAPK Signal Inactivation in an AD Cell Model. Brain Research, 1492, 33-45. [Google Scholar] [CrossRef] [PubMed]
[29] Salehi, B., Venditti, A., Sharifi-Rad, M., et al. (2019) The Therapeutic Potential of Apigenin. International Journal Molecular Sciences, 20, Article No. 1305. [Google Scholar] [CrossRef] [PubMed]
[30] Li, R., Robinson, M., Ding, X., et al. (2022) Genistein: A Focus on Several Neurodegenerative Diseases. Journal of Food Biochemistry, 46, e14155. [Google Scholar] [CrossRef] [PubMed]
[31] 谢悦. 锥体外系反应[C]//浙江省科学技术协会. 2019浙江省医学会肠外肠内营养学术大会暨江浙沪临床营养学术会议论文汇编: 2019年卷. 杭州: 医药卫生科技, 2019: 12.
[32] Duan, Y., Ying, Z., He, F., et al. (2021) A New Skeleton Flavonoid and a New Lignan from Portulaca oleracea L. and Their Activities. Fitoterapia, 153, Article ID: 104993. [Google Scholar] [CrossRef] [PubMed]
[33] Wang, L., Tu, Y.-C., Lian, T.-W., et al. (2006) Distinctive Anti-oxidant and Antiinflammatory Effects of Flavonols. Journal of Agricultural and Food Chemistry, 54, 9798-9804. [Google Scholar] [CrossRef] [PubMed]
[34] Parhiz, H., Roohbakhsh, A., Soltani, F., Rezaee, R., and Iranshahi, M. (2015) Antioxidant and Anti-Inflammatory Properties of the Citrus Flavonoids Hesperidin and Hesperetin: An Updated Review of Their Molecular Mechanisms and Experimental Models. Phytotherapy Research, 29, 323-331. [Google Scholar] [CrossRef] [PubMed]
[35] 乔靖怡, 李汉伟, 胡锴, 等. 马齿苋总黄酮对四氯化碳致大鼠急性肝损伤的保护作用[J]. 中药药理与临床, 2020, 36(5): 91-95.
[36] 王天宁, 刘玉婷, 肖凤琴, 等. 马齿苋化学成分及药理活性的现代研究整理[J]. 中国实验方剂学杂志, 2018, 24(6): 224-234.
[37] Zhao, C., Ying, Z., Tao, X., et al. (2018) A New Lactam Alkaloid from Portulaca oleracea L. and Its Cytotoxity. Natural Product Research, 32, 1548-1553. [Google Scholar] [CrossRef] [PubMed]
[38] Ma, Y., Li, X., Zhang, W., Ying, X. and Stien, D. (2021) A Trace Alkaloid, Oleraisoindole A from Portulaca oleracea L. and Its Anticholinesterase Effect. Natural Product Research, 35, 350-353. [Google Scholar] [CrossRef] [PubMed]
[39] Xu, W., Ying, Z., Tao, X., Ying, X. and Yang, G. (2021) Two New Amide Alkaloids from Portulaca oleracea L. and Their Anticholinesterase Activities. Natural Product Re-search, 35, 3794-3800. [Google Scholar] [CrossRef] [PubMed]
[40] 岳苏. 马齿苋酚性成分的分离及马齿苋酰胺E的药代动力学研究[D]: [硕士学位论文]. 济南: 山东大学, 2016.
[41] 李玲玉. 马齿苋酰胺E和马齿苋提取物的神经保护和抗炎活性研究[D]: [硕士学位论文]. 济南: 山东大学, 2018.
[42] Othman, A., Sayed, A.M., Amen, Y. and Shimizu, K. (2022) Possible Neuroprotective Effects of Amide Alkaloids from Bassia indica and Agathophora alopecu-roides: In Vitro and in Silico Investigations. RSC Advances, 12, 18746-18758. [Google Scholar] [CrossRef
[43] Kim, Y., Lim, H.J., Jang, H.J., et al. (2018) Portulaca oleracea Ex-tracts and Their Active Compounds Ameliorate Inflammatory Bowel Diseases in Vitro and in Vivo by Modulating TNF-α, IL-6 and IL-1β Signalling. Food Research International, 106, 335-343. [Google Scholar] [CrossRef] [PubMed]
[44] Wang, Z., Zeng, M., Wang, Z., et al. (2021) Dietary Luteolin: A Narrative Review Focusing on Its Pharmacokinetic Properties and Effects on Glycolipid Metabolism. Journal of Agri-cultural and Food Chemistry, 69, 1441-1454. [Google Scholar] [CrossRef] [PubMed]
[45] 叶梅荣, 王晓鹏, 刘爱荣, 等. 药食两用植物马齿苋的研究进展[J]. 安徽农业科学, 2017, 45(32): 140-141+164.
[46] 刘雪艳, 查代君. 黄酮类活性成分的代谢研究进展[J]. 福建医科大学学报, 2021, 55(4): 358-366.
[47] Murota, K., Nakamura, Y. and Uehara, M. (2018) Flavonoid Metabolism: The Interaction of Metabolites and Gut Microbiota. Bioscience, Biotechnology, and Biochemistry, 82, 600-610. [Google Scholar] [CrossRef] [PubMed]
[48] Barve, A., Chen, C., Hebbar, V., et al. (2009) Metabolism, Oral Bioavailability and Pharmacokinetics of Chemopreventive Kaempferol in Rats. Biopharmaceutics & Drug Disposi-tion, 30, 356-365. [Google Scholar] [CrossRef] [PubMed]
[49] Calderón-Montaño, J.M., Burgos-Morón, E., Pé-rez-Guerrero, C. and Lopez-Lazaro, M. (2011) A Review on the Dietary Flavonoid Kaempferol. Mini-Reviews in Medic-inal Chemistry, 11, 298-344. [Google Scholar] [CrossRef] [PubMed]
[50] Tang, D., Chen, K., Huang, L. and Li, J. (2017) Pharmacoki-netic Properties and Drug Interactions of Apigenin, a Natural Flavone. Expert Opinion on Drug Metabolism & Toxicolo-gy, 13, 323-330. [Google Scholar] [CrossRef] [PubMed]
[51] Ying, J.Y., Gu, S.J. and Yao, T.W. (2008) Research Pro-gress on Interactions between Luteolin (Glucosides) and Drug-Metabolizing Enzyme. Acta Pharmaceutica Sinica, 43, 335-342.
[52] Yeh, S.-L., Lin, Y.-C., Lin, Y.-L., et al. (2016) Comparing the Metabolism of Quercetin in Rats, Mice and Gerbils. European Journal of Nutrition, 55, 413-422. [Google Scholar] [CrossRef] [PubMed]
[53] Li, H., Li, H., Jiang, S., et al. (2022) Study of the Metabolism of Myricetin in Rat Urine, Plasma and Feces by Ul-tra-High-Performance Liquid Chromatography. Biomedical Chromatography, 36, e5281. [Google Scholar] [CrossRef] [PubMed]
[54] Huang, T., Liu, Y. and Zhang, C. (2019) Pharmacokinetics and Bioavailabil-ity Enhancement of Baicalin: A Review. European Journal of Drug Metabolism and Pharmacokinetics, 44, 159-168. [Google Scholar] [CrossRef] [PubMed]
[55] Zhang, J., Cai, W., Zhou, Y., et al. (2015) Profiling and Identifi-cation of the Metabolites of Baicalin and Study on Their Tissue Distribution in Rats by Ultra-High-Performance Liquid Chromatography with Linear Ion Trap-Orbitrap Mass Spectrometer. Journal of Chromatography B, 985, 91-102. [Google Scholar] [CrossRef] [PubMed]
[56] Luo, C.-F., Cai, B., Hou, N., et al. (2012) UDP-Glucuronosyltransferase 1A1 Is the Principal Enzyme Responsible for Puerarin Metabolism in Human Liver Mi-crosomes. Archives of Toxicology, 86, 1681-1690. [Google Scholar] [CrossRef] [PubMed]
[57] Chitsazan, M. and Chitsazan, M. (2023) The Role of Free Fatty Acids as a Prognostic Biomarker in Coronary Artery Disease Patients with Type 2 Diabetes. European Journal of Pre-ventive Cardiology, 30, 728-729. [Google Scholar] [CrossRef] [PubMed]
[58] Qin, J., Chen, J., Peng, F., et al. (2022) Pharmacological Activities and Pharmacokinetics of Liquiritin: A Review. Journal of Ethnopharmacology, 293, Article ID: 115257. [Google Scholar] [CrossRef] [PubMed]
[59] Peng, Y., Gan, R., Li, H., et al. (2021) Absorption, Metabolism, and Bioactivity of Vitexin: Recent Advances in Understanding the Efficacy of an Important Nutraceutical. Critical Re-views in Food Science Nutrition, 61, 1049-1064. [Google Scholar] [CrossRef] [PubMed]
[60] 陈彦, 王晋艳, 贾晓斌, 等. 枳实中主要二氢黄酮类成分肠道吸收代谢及与药物相互作用的研究进展[J]. 中草药, 2010, 41(9): 1564-1566.
[61] Yang, X., Ying, Z., He, F., et al. (2018) A Pharmacokinetic Study on Oleracone C after Oral and Intravenous Administration. Fitoterapia, 131, 44-49. [Google Scholar] [CrossRef] [PubMed]
[62] Lin, L.-C., Pai, Y.-F. and Tsai, T.-H. (2015) Isolation of Luteolin and Luteolin-7-O-Glucoside from Dendranthema morifolium Ramat Tzvel and Their Pharmacokinetics in Rats. Journal of Agricultural and Food Chemistry, 65, 6-10. [Google Scholar] [CrossRef] [PubMed]
[63] Xiu, F., Ying, Z., Ying, X. and Yang, G. (2019) Pharmacokinetic Studies of Soyalkaloid A from Portulaca oleracea L. Using Ultra High-Performance Liquid Chromatography Electrospray Ioniza-tion Quadrupole-Time of Flight Mass Spectrometry and Its Antioxidant Activity. Biomedical Chromatography, 33, e4399. [Google Scholar] [CrossRef] [PubMed]
[64] Meng, Y., Ying, Z., Xiang, Z., et al. (2016) The Anti-Inflammation and Pharmacokinetics of a Novel Alkaloid from Portulaca oleracea L. Journal of Pharmacy Pharmacology, 68, 397-405. [Google Scholar] [CrossRef] [PubMed]
[65] Ying, Z., Li, C., Gao, M., Ying, X. and Yang, G. (2018) Pharmacokinetics and Metabolism of Olerciamide A from Portulaca oleracea L. in Rats by UHPLC-UV and UHPLC-ESI-Q-TOF/MS. Biomedical Chromatography, 32, e4061. [Google Scholar] [CrossRef] [PubMed]
[66] Chen, L., Liu, Y., Jia, D., et al. (2016) Pharmacokinetics and Biodistribution of Aurantiamide and Aurantiamide Acetate in Rats after Oral Administration of Portulaca oleracea L. Extracts. Journal of Agricultural and Food Chemistry, 64, 3445-3455. [Google Scholar] [CrossRef] [PubMed]
[67] 郑腾晔, 陈天新, 蔡露茜, 黄朝兴. 食用马齿苋野菜后发生急性肾衰竭2例报告[J]. 中国中西医结合肾病杂志, 2021, 22(10): 930-931+944.